These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34893067)

  • 1. In vivo alterations of mitochondrial activity and amyloidosis in early-stage senescence-accelerated mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Ikegaya S; Kakiuchi T; Ohba H; Nishiyama S; Fukomoto D; Kanazawa M; Harada N; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2021 Dec; 18(1):288. PubMed ID: 34893067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease.
    Terada T; Therriault J; Kang MS; Savard M; Pascoal TA; Lussier F; Tissot C; Wang YT; Benedet A; Poltronetti NM; Ottoy J; Arias JF; Bezgin G; Matsudaira T; Bunai T; Obi T; Tsukada H; Ouchi Y; Rosa-Neto P
    Eur J Neurol; 2022 May; 29(5):1324-1334. PubMed ID: 35007366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease.
    Terada T; Therriault J; Kang MSP; Savard M; Pascoal TA; Lussier F; Tissot C; Wang YT; Benedet A; Matsudaira T; Bunai T; Obi T; Tsukada H; Ouchi Y; Rosa-Neto P
    Mol Neurodegener; 2021 Apr; 16(1):28. PubMed ID: 33902654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients.
    Byun BH; Kim BI; Park SY; Ko IO; Lee KC; Kim KM; Kim YK; Lee JY; Bu SH; Kim JH; Chi DY; Ha JH; Lim SM
    Medicine (Baltimore); 2017 Mar; 96(12):e6441. PubMed ID: 28328855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys.
    Tsukada H; Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Harada N
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2127-36. PubMed ID: 24919653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease.
    Terada T; Obi T; Bunai T; Matsudaira T; Yoshikawa E; Ando I; Futatsubashi M; Tsukada H; Ouchi Y
    Neurology; 2020 Apr; 94(15):e1592-e1604. PubMed ID: 32139504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and clinical study on [
    Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study in comparison with 18F-BMS-747158-02 in rat brain.
    Tsukada H; Nishiyama S; Fukumoto D; Kanazawa M; Harada N
    J Nucl Med; 2014 Mar; 55(3):473-80. PubMed ID: 24470629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing α7 nicotinic acetylcholine receptor binding, amyloid-β deposition, and mitochondria complex-I function in living brain: A PET study in aged monkeys.
    Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Tsukada H
    Synapse; 2015 Oct; 69(10):475-83. PubMed ID: 26234533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of the mechanism of changes in the antioxidant function with the aging in the liver of the senescence-accelerated mouse P10 (SAMP10).
    Kawahara T; Kita T; Ueno Y; Yamasaki S; Kimura G; Nakanishi M; Hosokawa T; Kurasaki M; Sikder T; Saito T
    Exp Gerontol; 2018 Jun; 106():46-53. PubMed ID: 29477336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional correlations between [
    Seo SW; Ayakta N; Grinberg LT; Villeneuve S; Lehmann M; Reed B; DeCarli C; Miller BL; Rosen HJ; Boxer AL; O'Neil JP; Jin LW; Seeley WW; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2017; 13():130-137. PubMed ID: 27981028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study.
    Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A
    J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases.
    Biechele G; Franzmeier N; Blume T; Ewers M; Luque JM; Eckenweber F; Sacher C; Beyer L; Ruch-Rubinstein F; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Cumming P; Bartenstein P; Rominger A; Höglinger GU; Herms J; Brendel M
    J Neuroinflammation; 2020 Dec; 17(1):374. PubMed ID: 33317543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain.
    Tsukada H; Ohba H; Nishiyama S; Kanazawa M; Kakiuchi T; Harada N
    J Cereb Blood Flow Metab; 2014 Apr; 34(4):708-14. PubMed ID: 24447952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain.
    Harada N; Nishiyama S; Kanazawa M; Tsukada H
    J Labelled Comp Radiopharm; 2013 Sep; 56(11):553-61. PubMed ID: 24285187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
    Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis.
    Knopman DS; Jack CR; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    JAMA Neurol; 2013 Aug; 70(8):1030-8. PubMed ID: 23797806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
    Klunk WE; Lopresti BJ; Ikonomovic MD; Lefterov IM; Koldamova RP; Abrahamson EE; Debnath ML; Holt DP; Huang GF; Shao L; DeKosky ST; Price JC; Mathis CA
    J Neurosci; 2005 Nov; 25(46):10598-606. PubMed ID: 16291932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.